Evidence map›Paper›PMID 42141332›Full record

ArticleInsights into imaging2026

MRI- and report-based multimodal model with SHAP-based explanation for preoperative prediction of deep stromal invasion in early-stage cervical cancer.

Raoying Xie, Yao Ai, Anqi Bao, Lihua Xie, Wenjing Wang, Kangwei Zhu, Jianping Wu, Yiyang Wu, Ruyan Xiong, Xiance Jin

Abstract read
In one paragraph

Article in Insights into imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Raoying Xie *Department of Radiation and Medical Oncology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Yao Ai *Department of Radiation and Medical Oncology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Anqi BaoDepartment of Radiation and Medical Oncology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Lihua XieDepartment of Radiotherapy and Chemotherapy, The second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Wenjing WangDepartment of Radiation and Medical Oncology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Kangwei ZhuDepartment of Radiation and Medical Oncology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Jianping WuDepartment of Radiation and Medical Oncology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Yiyang WuDepartment of Radiation and Medical Oncology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Ruyan XiongDepartment of Radiation and Medical Oncology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Xiance JinDepartment of Radiation and Medical Oncology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. jinxc1979@hotmail.com.ORCID http://orcid.org/0000-0002-4117-5953

Funding

National Natural Science Foundation 12475352Natural Science Foundation of Zhejiang Province LZ24A050008
6 · The paper itself

Abstract

objectivesDepth of stromal invasion (DSI) is a key prognostic factor significantly influencing treatment decisions in early-stage cervical cancer (ESCC). This study aims to develop an explainable multimodal data fusion model integrating MRI, radiology reports, and clinical variables for the preoperative assessment of DSI risk. MATERIALS AND

methodsRadiomic features were extracted from preoperative sagittal T2-weighted imaging (T2WI). Bidirectional Encoder Representations from Transformers (BERT) features were derived from the corresponding radiology reports using natural language processing (NLP). Key BERT and radiomic features were selected using the least absolute shrinkage and selection operator (LASSO). Independent clinical risk factors were identified through univariate analysis, followed by multivariate logistic regression. Five machine learning algorithms were employed to construct the clinical (C), text (T), radiomic (R), and multimodal fusion models (T + R, T + R + C). The Shapley Additive exPlanation (SHAP) method interpreted the optimal fusion model.

resultsOverall, 498 radiomic features (from T2WI) and 384 BERT-derived features (from reports) were extracted per patient. LASSO selected eleven BERT features and nine radiomic features; multivariate analysis identified two independent clinical risk factors. The text-radiomic-clinical fusion model (T + R + C) outperformed all other models, achieving AUCs of 0.912, 0.874, and 0.890 in the training, internal validation, and external validation cohorts, respectively. SHAP analysis revealed that eight BERT features, five radiomic features, and two clinical features ranked among the top 15 most influential predictors.

conclusionThe explainable multimodal model improves preoperative DSI risk evaluation in ESCC. However, given the small external cohort (n = 20), these results are preliminary and require further independent multi-center validation before clinical application. CRITICAL RELEVANCE: The developed model significantly improves preoperative DSI prediction in ESCC through noninvasive imaging analysis, thereby refining risk assessment and guiding precision oncology interventions. KEY POINTS: DSI is a key prognostic factor significantly influencing treatment decisions in ESCC. The explainable multimodal fusion model was established. The accuracy of preoperative DSI risk evaluation was beneficial for clinical decision-making.

Indexed as

Depth of stromal invasionEarly-stage cervical cancerMachine learningNatural language processingRadiomics

Identifiers

PMID42141332
PMCPMC13179407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.